TME Pharma N.V. announced a private placement to issue common share and convertible debt for the gross proceeds of ?2,700,000 on November 24, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.245 EUR | -3.54% | +0.62% | +6.52% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.52% | 7.76M | |
+24.07% | 46.71B | |
+48.83% | 41.8B | |
-0.81% | 41.52B | |
-5.86% | 29.55B | |
+11.08% | 25.78B | |
-20.35% | 19.26B | |
+2.89% | 12.14B | |
-3.08% | 12.08B | |
+30.16% | 11.98B |
- Stock Market
- Equities
- ALTME Stock
- News TME Pharma N.V.
- TME Pharma N.V. announced that it expects to receive ?2.7 million in funding